Acetic Acid → {3-[(2R)-2-((2R)-2-Hydroxy-2-pyridin-3-ylethylamino)propyl]-1H-indol-7-yloxy}acetic acid
Reaction equation
C(N(CC)[C:4](=[O:29])[CH2:5][O:6][C:7]1[CH:8]=[CH:9][CH:10]=[C:11]2[C:15]=1[NH:14][CH:13]=[C:12]2[CH2:16][C@H:17]([NH:19][CH2:20][C@H:21]([OH:28])[C:22]1[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=1)[CH3:18])C.[OH-].[K+].C([OH:36])C.C(O)(=O)C>O>[OH:28][C@H:21]([C:22]1[CH:23]=[N:24][CH:25]=[CH:26][CH:27]=1)[CH2:20][NH:19][C@H:17]([CH3:18])[CH2:16][C:12]1[C:11]2[C:15](=[C:7]([O:6][CH2:5][C:4]([OH:29])=[O:36])[CH:8]=[CH:9][CH:10]=2)[NH:14][CH:13]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of N,N-diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)propyl]-1H-indol-7-yloxy}acetamide (30 mg, 0.071 mmol) and potassium hydroxide (120 mg, 2.1 mmol) in water (1 mL)/ethanol (1 mL) is stirred at 60° C. for 6 hours. After cooling, to the mixture is added acetic acid (0.112 mL), and the mixture is concentrated. The residue is purified by preparative reversed phase HPLC (octadecylsilyl, trade name: Combiprep, ODS-A (YMC), inner diameter: 50×20 mm, particle size: 5 μm, pore size: 120 angstrom (hereinafter, this column is used in preparative reversed phase HPLC column), 0.05% trifluoroacetic acid/water-0.035% trifluoroacetic acid/acetonitrile) to give the desired {3-[(2R)-2-((2R)-2-hydroxy 2-pyridin-3-yl-ethylamino)propyl]-1H-indol-7-yloxy}acetic acid.2 trifluoroacetate (24 mg, yield: 57%).
Workup
- temperatureAfter cooling, to the mixture
- concentrationthe mixture is concentrated
- customThe residue is purified by preparative reversed phase HPLC (octadecylsilyl, trade name
Sources & evidence
- ORD record
- ord-9a4bcc636576421db98490f2b2ce531b
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07217724B2
Reaction notes
Loading…